Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Michael J. Fox Foundation

MJFF awards $6m to Lario Therapeutics for Parkinson’s research

MJFF awards m to Lario Therapeutics for Parkinson’s research
p p Read More

The neurological disease is estimated to affect more than ten million people globally

July 23, 2024 CaV2.3 calcium channel inhibition, Michael J. Fox Foundation, neurodegenerative diseases, neurological conditions, News, Parkinson's disease

Mission awarded $5.2m to advance potential Parkinson’s treatment

Mission awarded .2m to advance potential Parkinson’s treatment
p p Read More

The progressive neurodegenerative condition affects around 153,000 people in the UK

July 8, 2024 Michael J. Fox Foundation, Mission Therapeutics, MTX325, neurodegenerative diseases, News, Parkinson's disease, Parkinson’s UK

Herantis Pharma granted €3.6m to assess treatment for Parkinson’s disease

Herantis Pharma granted €3.6m to assess treatment for Parkinson’s disease
p p Read More

The progressive neurological condition affects around 153,000 people in the UK

July 4, 2024 HER-096, Herantis Pharma, Michael J. Fox Foundation, News, Parkinson's disease, Parkinson's UK Virtual Biotech Programme

LucyTx announces additional $12.5m research funding for neurological diseases

LucyTx announces additional .5m research funding for neurological diseases
p p Read More

Alzheimer’s and Parkinson’s disease are responsible for more than 30 million cases globally

June 11, 2024 Alzheimer's disease, Bill & Melinda Gates Foundation, Lucy Therapeutics, Michael J. Fox Foundation, neurological conditions, News, Parkinson's disease, Parkinson’s UK, Rett syndrome, Safar Partners
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy